Zymeworks (ZYME) Research & Development (2021 - 2026)
Zymeworks (ZYME) recorded Research & Development of $27.44 million in Q2 2026, down 20.4% from $34.45 million a year earlier and down 20.4% from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Research & Development (2021 - 2026) Analysis & Trends
On a TTM basis, Zymeworks' Research & Development came in at $128.71 million as of Jun 30, 2026, down 10.4% year-over-year; for FY2025, it was $137 million, up 1.8% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -4.4% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $134.62 million in FY2024 (-6.3%), $143.62 million in FY2023 (-31.1%), $208.6 million in FY2022 (+4.4%) and $199.75 million in FY2021 (+16.7%).
- The Q2 2026 figure is the lowest quarterly Research & Development since Q4 2023.
- On a year-over-year basis, Research & Development has declined for four consecutive quarters, with growth averaging 5.5% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 45.2% in Q4 2024, against a decline of 51.8% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $34.46 million (Q1 2026), $31.24 million (Q4 2025) and $35.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Zymeworks | 2.24 Bn | 1.27 Bn | - | 36.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.13 Mn |
| Jun 30, 2026 | 27.44 Mn |
| Mar 31, 2026 | 34.46 Mn |
| Dec 31, 2025 | 31.24 Mn |
| Sep 30, 2025 | 35.58 Mn |
| Jun 30, 2025 | 34.45 Mn |
| Mar 31, 2025 | 35.74 Mn |
| Dec 31, 2024 | 37.06 Mn |
| Sep 30, 2024 | 36.35 Mn |
| Jun 30, 2024 | 29.16 Mn |
| Mar 31, 2024 | 32.04 Mn |
| Dec 31, 2023 | 25.52 Mn |
| Sep 30, 2023 | 32.78 Mn |
| Jun 30, 2023 | 39.41 Mn |
| Mar 31, 2023 | 45.91 Mn |
| Dec 31, 2022 | 52.97 Mn |
| Sep 30, 2022 | 37.10 Mn |
| Jun 30, 2022 | 56.02 Mn |
| Mar 31, 2022 | 62.51 Mn |
| Dec 31, 2021 | 54.87 Mn |
API Access
Zymeworks Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();